Previous 10 | Next 10 |
2023-11-11 16:22:05 ET SOPHiA GENETICS SA (SOPH) Q3 2023 Results Conference Call November 07, 2023 08:00 AM ET Company Participants Katherine Bailon - Head, IR Dr. Jurgi Camblong - Co-Founder and CEO Ross Muken - CFO and COO Conference Call Participants ...
2023-11-07 07:18:36 ET More on SOPHiA Genetics SOPHiA GENETICS SA (SOPH) Q2 2023 Earnings Call Transcript SOPHiA GENETICS expands relationship with Gustave Roussy Seeking Alpha’s Quant Rating on SOPHiA Genetics Historical earnings data for SOPHiA Genet...
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ PR Newswire World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON and ELMWOOD PAR...
BOSTON and ROLLE, Switzerland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for the third quarter ended September 30, 2023. Recent Highlights Revenue for ...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
SOPHiA GENETICS SA (SOPH) is expected to report $-0.32 for Q3 2023
BOSTON and GENEVA, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the third quarter of fiscal 2023 before U.S. markets open on Tu...
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care Canada NewsWire The three companies will collaborate to improve global access to advanced cancer testing and data, b...
Shaare Zedek Medical Center Uses SOPHiA GENETICS to Advance Research of Myeloid Disorders PR Newswire The hospital will use the SOPHiA DDM™ Platform to further its work with myeloid disorders and advance the development of precision medicine BOSTON and ROLLE...
Laboratorio Curie Expands Relationship with SOPHiA GENETICS PR Newswire The SOPHiA DDM™ Platform will help Laboratorio Curie advance its research into BRCA gene mutations BOSTON and ROLLE, Switzerland , Sept. 13, 2023 /PRNewswire/ -- SOPHiA GEN...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...